| Literature DB >> 36077473 |
Beáta Čižmárová1, Vladimíra Tomečková1, Beáta Hubková1, Anna Hurajtová1, Jana Ohlasová1, Anna Birková1.
Abstract
Homeostasis is a self-regulatory dynamic process that maintains a stable internal environment in the human body. These regulations are essential for the optimal functioning of enzymes necessary for human health. Homeostasis elucidates disrupted mechanisms leading to the development of various pathological conditions caused by oxidative stress. In our work, we discuss redox homeostasis and salivary antioxidant activity during healthy periods and in periods of disease: dental carries, oral cavity cancer, periodontal diseases, cardiovascular diseases, diabetes mellitus, systemic sclerosis, and pancreatitis. The composition of saliva reflects dynamic changes in the organism, which makes it an excellent tool for determining clinically valuable biomarkers. The oral cavity and saliva may form the first line of defense against oxidative stress. Analysis of salivary antioxidants may be helpful as a diagnostic, prognostic, and therapeutic marker of not only oral, but also systemic health.Entities:
Keywords: antioxidant; disease; homeostasis; saliva
Mesh:
Substances:
Year: 2022 PMID: 36077473 PMCID: PMC9455999 DOI: 10.3390/ijms231710076
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Reactive species, their sources and effects. Legend: NO-nitric oxide, NOS-nitric oxide synthase, NADPH-oxidase-nicotinamide adenine dinucleotide phosphate oxidase, LMW-low molecular weight, XO-xanthine oxidase, LOX-lipooxygenase, COX-cyclooxygenase, AGE-advanced glycation end products, MDA-malondialdehyde, 4-HNE-4-hydroxynonenal.
Salivary redox markers in various pathological states.
| State | Marker | Finding | References | Notes |
|---|---|---|---|---|
|
| TAC | ↑ | [ | |
| SOD | ↓ | [ | ||
| Px | ↑ | [ | ||
| UA | ↑ | |||
| CAT | ↑ | [ | ||
| GPx | ↑ | |||
| MDA | ↑ | [ | Early childhood caries | |
|
| Px | ↓ | [ | |
| SOD | ↓ | [ | ||
| GPx | ↓ | [ | ||
|
| UA | ↓ | [ | |
| Px | ↓ | [ | ||
| SOD | ↓ | [ | ||
| GST | ↑ | |||
| MDA | ↑ | [ | Data from meta-analysis | |
|
| SOD | ↓ | [ | After treatment |
| TAC | ↑ | [ | ||
| ALB | ↑ | [ | ||
| UA | ↑ | |||
| GPx | ↑ | |||
| MDA | ↑ | [ | Treatment does not improve levels significantly | |
| NO | ↑ | [ | ||
| 8-OHdG | ↑ | [ | Improved levels after treatment, also in diabetics | |
| 4-HNE | ↑ | In diabetes | ||
| AGE | ↑ | |||
| RAGE | ↑ | |||
|
| TP | ↓ | [ | Mainly submandibular salivary glands |
| A | ↓ | |||
| SOD | ↑ | |||
| CAT | ↑ | |||
| Px | ↓ | |||
| GSH | ↓ | |||
| UA | ↑ | |||
| TAC | ↓ | |||
| TOS | ↑ | |||
| TAC/TOS ratio | ↑ | |||
| ROSP | ↑ | |||
| AGE | ↑ | Correlation with AGE plasma levels, serum NT-proBNP | ||
| MDA | ↑ | Correlation with plasma levels | ||
| AOPP | ↑ | |||
|
| TAC | ↓ | [ | No correlation to serum levels |
| SOD | ↓ | |||
| CAT | ↓ | |||
| GPx | ↓ | |||
|
| AA | ↓ | [ | More significant in STEMI, improvement in antioxidant activity after 6–5 weeks simultaneously with clinical status |
|
| TAC | ↓ | [ | |
| CAT | ↓ | |||
| TOS | ↑ | |||
| MDA | ↑ | |||
| GPx | ↑ | [ | Good metabolic control | |
| GR | ↑ | Good metabolic control | ||
| GSSG/GSH | ↑ | |||
|
| SOD | ↓ | [ | In rats, correlation with blood levels |
| ASCA | ↓ | |||
| GSH | ↓ | In rats, correlation with blood levels, body weight, BMI, glucose, insulin, HOMA-IR, leptin, resistin and TNF-α | ||
| PC | ↑ | In rats, correlation with blood levels | ||
| 4-HNE | ↑ | In rats, correlation with blood levels, body weight, BMI, glucose, insulin, HOMA-IR, leptin, resistin and TNF-α | ||
| AGE | ↑ | In rats, correlation with blood levels | ||
| 3-NT | ↑ | |||
|
| UA | ↓ | [ | |
| TAS | ↓ | |||
| Px | ↓ | |||
| CAT | ↓ | |||
| MDA | ↑ | |||
| TOS | ↑ | |||
| TT | ↑ | |||
|
| log PC | ↑ | [ | Non-significant enhanced protein oxidation without concomitant lipid peroxidation and DNA damage |
| Px | ↓ | [ | In hyposalivation | |
| SOD | ↓ | |||
| UA | ↓ | |||
| TAS | ↓ | |||
|
| AGE | ↑ | [ | Correlates with plasma levels |
| 8-OHdG | ↑ | |||
| CML | ↑ | |||
| CL | ↑ | |||
| TT | ↓ | |||
| PC | ↑ | |||
| 4-HNE | ↑ | |||
| GSSG | ↓ | [ | ||
|
| β2MG | ↑ | [ | |
| SOD | ↓ | [ | In rats, from salivary gland homogenates | |
| GR | ↓ | |||
| GSH | ↓ | |||
| A | ↑ |
TAC–total antioxidant capacity, TAS–total antioxidant status, SOD–superoxid dismutase, TT–total thiols, TOS–total oxidative stress, UA–uric acid, MDA–malondialdehyde, Px–peroxidase, CAT–catalase, GPx–glutathion peroxidase, GR–glutathion reductase, GSSG–oxidized glutathion, GSH–reduced glutathion, β2MG-β2-microglobulin, PC–protein carbonyls, A–amylase, AA–antioxidant activity, AOPP-advanced oxidation protein products, AGE-advanced glycation end products, ASCA–ascorbic acid, ROSP–ROS production, TP–total protein, NO-nitric oxide, 8-OHdG–8-hydroxydeoxyguanosine, 4-HNE–4-hydroxynonenal, 3-NT–3-nitrotyrosine, CML–carboxymethyl-lysine, CL–carbamyl-lysine, ALB–albumin, GST–glutathion S transferase, SS–Systemic sclerosis, PCT–pancreatitis, DM2–diabetes mellitus type 2, IR–insulin resistence, GDM–gestational diabetes mellitus, ACS-acute coronary syndrome, CHD-coronary heart disease, HF-heart failure, PO–periodontitis, OC-oral cancer, SM–smoking, DC-dental caries.